Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-09-19Clinical Trial Update: Effects of Electrical Baroreflex Stimulation on Sympathetic Activity, Renal Hemodynamics, and Insulin Sensitivity
An update on a clinical trial evaluating electrical baroreflex stimulation and its effects on sympathetic activity, renal hemodynamics, and …
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: TC-5214 as Augmentation Therapy in Patients With Refractory Hypertension [Phase 1, Phase 2]
TC-5214 was studied as augmentation therapy for refractory hypertension in a Phase 1/2 trial that has been terminated.
-
FDA approval · 2013-09-12FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2013-09-11Clinical Trial Update: COMPLIANCE An Observational Study of Treatment Compliance and Quality of Life in Patients on Antihypertensive Medication
AstraZeneca-sponsored observational study assessing treatment adherence and quality of life in patients taking antihypertensive medications.
-
FDA approval · 2013-09-10FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis's supplemental application for a generic lisinopril and hydrochlorothiazide tablet, expanding the approval to inclu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Effect of a Community-based Nursing Intervention on Mortality in Chronically Ill Older Adults [NA]
Clinical trial update evaluating a community-based nursing intervention on mortality in chronically ill older adults. The study includes par…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Exercise and Blood Pressure Reactivity
This clinical trial update notes the completion of a study examining how exercise affects blood pressure reactivity in people with hypertens…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients. [Phase 4]
Phase 4 clinical trial evaluating the pharmacodynamic effects of candesartan, atenolol, hydrochlorothiazide, and their combinations in hyper…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®
A completed Bayer-sponsored clinical trial update evaluating Kinzal and Kinzalplus for treating essential hypertension.
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Evaluation of a Navigator-Nurse Care Team on the Management of High Blood Pressure and Cardiovascular Disease Risk [NA]
This update reports a completed clinical trial evaluating whether a navigator-nurse care team improves management of hypertension and cardio…
-
FDA approval · 2013-08-30FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approves Teva Pharmaceuticals’ supplemental application for amlodipine besylate (generic) under ANDA076846. This action represents an ap…
-
FDA approval · 2013-08-30FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for amlodipine besylate from Epic Pharma, enabling the generic product to be marketed.
-
CLINICAL_TRIALS research · 2013-08-30Clinical Trial Update: The SMART-ORACLE Study
The SMART-ORACLE study, sponsored by UMC Utrecht, has an update on ClinicalTrials.gov. The listed conditions include coronary artery disease…
-
FDA approval · 2013-08-29FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for the irbesartan and hydrochlorothiazide combination from Alembic Pharmaceuticals Limited, authori…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of a fixed-dose combination of lercanidipine/valsartan in adults with hypertension has co…
-
FDA approval · 2013-08-27FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from Macleods Pharmaceuticals Limited, authorizin…
-
CLINICAL_TRIALS trial_result · 2013-08-27Clinical Trial Update: The Prevalence of Coronary Spasm in Hypertensive Patients Treated With Antihypertensive Medication
This clinical trial update reports on the prevalence of coronary artery spasm in hypertensive patients treated with antihypertensive medicat…
-
FDA approval · 2013-08-26FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved the supplemental application for amlodipine besylate from Lupin Pharmaceuticals, making its generic calcium channel blocker ava…
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension [Phase 3]
Phase 3 trial update from AstraZeneca reports efficacy and safety results in patients with type 2 diabetes mellitus, cardiovascular disease …
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Clinical Study for Patients With Hypertension Associated With Dyslipidemia [Phase 3]
A Phase 3 clinical study for patients with hypertension associated with dyslipidemia sponsored by Daewoong Pharmaceutical has completed.
-
FDA approval · 2013-08-16FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
FDA approved a supplemental application for generic lisinopril from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals), authorizing a cha…
-
FDA approval · 2013-08-14FDA Approved: LISINOPRIL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for lisinopril from Actavis Pharma, Inc., authorizing the marketing of a generic lisinopril product.
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia [Phase 3]
Phase 3 study evaluating the efficacy and safety of combined irbesartan and atorvastatin therapy in adults with hypertension and hyperlipide…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168) [Phase 3]
Phase 3 trial assessing whether statin therapy can reduce left ventricular hypertrophy in hypertensive patients; the study MK0653A-168 was t…
-
CLINICAL_TRIALS research · 2013-08-13Clinical Trial Update: Placebo Effects on Blood Pressure Induced by Expectancy Manipulation [NA]
A completed clinical trial from Ludwig-Maximilians-Universität München examining whether expectancy and placebo effects can alter blood pres…